HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hye-Jeong Lee Selected Research

Hypoxia (Hypoxemia)

11/2018Withdrawal: AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells.
12/2004AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells.
10/2003AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hye-Jeong Lee Research Topics

Disease

12Neoplasms (Cancer)
10/2018 - 12/2004
7Atrial Fibrillation
11/2021 - 08/2011
6Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2020 - 06/2015
6Thrombosis (Thrombus)
10/2018 - 09/2011
6Cardiomyopathies (Cardiomyopathy)
01/2018 - 01/2016
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2016 - 08/2011
4Cardiotoxicity
06/2022 - 01/2016
4Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 10/2012
4Adenocarcinoma of Lung
01/2020 - 01/2016
4Coronary Artery Disease (Coronary Atherosclerosis)
09/2017 - 02/2011
4Stroke (Strokes)
05/2014 - 06/2009
4Type 2 Diabetes Mellitus (MODY)
10/2012 - 01/2009
4Body Weight (Weight, Body)
04/2010 - 04/2007
3Fibrosis (Cirrhosis)
01/2021 - 01/2018
3Hypoxia (Hypoxemia)
11/2018 - 10/2003
3Adenocarcinoma
04/2018 - 03/2013
3Stomach Neoplasms (Stomach Cancer)
01/2013 - 01/2011
3Insulin Resistance
10/2012 - 01/2009
3Hypercholesterolemia
02/2011 - 04/2010
2Heart Neoplasms
01/2022 - 10/2018
2Dyslipidemias (Dyslipidemia)
11/2021 - 05/2010
2Infections
09/2021 - 06/2010
2Inflammation (Inflammations)
01/2021 - 09/2013
2Ischemic Stroke
01/2019 - 02/2015
2Cardiac Arrhythmias (Arrythmia)
10/2018 - 02/2009
2Cardiac Sudden Death (Sudden Cardiac Arrest)
10/2018 - 11/2016
2Lung Neoplasms (Lung Cancer)
01/2018 - 03/2015
2Neoplasm Metastasis (Metastasis)
01/2018 - 03/2011
2Chest Pain (Chest Pains)
02/2015 - 09/2012
2Embolism (Embolus)
12/2014 - 06/2009
2Carcinogenesis
05/2010 - 12/2004
2Glioma (Gliomas)
09/2008 - 12/2005
2Paragonimiasis
10/2002 - 06/2002
2Clonorchiasis
10/2002 - 06/2002
1Prolapse
11/2021
1Hypertension (High Blood Pressure)
11/2021
1Mitral Valve Insufficiency (Mitral Regurgitation)
11/2021
1Bundle-Branch Block (Fascicular Block)
11/2021
1Wounds and Injuries (Trauma)
01/2021
1Stomatitis
01/2021
1Lung Diseases (Lung Disease)
01/2021
1Edema (Dropsy)
01/2021
1Necrosis
01/2018
1Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
01/2018
1Left Ventricular Dysfunction
01/2018
1Pleural Effusion (Pleural Effusions)
01/2018
1Heart Failure
09/2017
1Thymoma (Thymic Carcinoma)
05/2017
1Airway Obstruction (Choking)
11/2016
1Ventricular Tachycardia
11/2016
1Ventricular Fibrillation
11/2016
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2016
1Sarcoma (Soft Tissue Sarcoma)
09/2016
1Pulmonary Embolism
09/2016

Drug/Important Bio-Agent (IBA)

10IodineIBA
10/2018 - 06/2012
9GadoliniumIBA
01/2022 - 05/2008
6Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2012
5CalciumIBA
01/2019 - 09/2008
5Tumor Biomarkers (Tumor Markers)IBA
03/2016 - 08/2011
4AnthracyclinesIBA
06/2022 - 01/2016
4Pharmaceutical PreparationsIBA
01/2021 - 04/2007
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 07/2013
4Fenofibrate (CiL)FDA LinkGeneric
06/2012 - 04/2007
3AMP-Activated Protein KinasesIBA
11/2018 - 10/2003
3Contrast MediaIBA
11/2016 - 03/2015
3antigen CYFRA21.1IBA
03/2016 - 09/2012
3Adenosine Triphosphate (ATP)IBA
10/2012 - 10/2003
3Glucose (Dextrose)FDA LinkGeneric
07/2012 - 10/2003
3Proteins (Proteins, Gene)FDA Link
06/2010 - 06/2002
2omega-Chloroacetophenone (Mace)IBA
02/2022 - 01/2020
2AntigensIBA
01/2021 - 06/2002
2CollagenIBA
01/2021 - 01/2016
2Tyrosine Kinase InhibitorsIBA
01/2018 - 01/2016
23,4-methylenedioxyethamphetamine (MDEA)IBA
01/2018 - 04/2017
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2016 - 03/2013
2squamous cell carcinoma-related antigenIBA
03/2016 - 08/2011
2Carcinoembryonic AntigenIBA
03/2016 - 08/2011
2Triglycerides (Triacylglycerol)IBA
07/2012 - 04/2010
2Atorvastatin (Lipitor)FDA Link
02/2011 - 12/2010
2TNF-Related Apoptosis-Inducing LigandIBA
12/2010 - 12/2005
2Transcription Factors (Transcription Factor)IBA
12/2004 - 10/2003
1VaccinesIBA
09/2021
1Broadly Neutralizing AntibodiesIBA
09/2021
1CosmeceuticalsIBA
01/2021
1CarbohydratesIBA
01/2021
1B7-H1 AntigenIBA
01/2020
1Deoxycytidine Monophosphate (DCMP)IBA
10/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1KryptonIBA
11/2016

Therapy/Procedure

5Therapeutics
01/2018 - 02/2013
5Catheter Ablation
06/2017 - 08/2011
3Drug Therapy (Chemotherapy)
01/2021 - 01/2017
3Radiofrequency Ablation
01/2018 - 10/2013
3CT protocol
07/2013 - 09/2011
2Gastrectomy
01/2013 - 01/2011
1Percutaneous Coronary Intervention
09/2017
1Patient Readmission
09/2017
1Heart Transplantation (Grafting, Heart)
09/2017
1Contraindications
04/2017
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
11/2016